Countermeasures Injury Compensation Program (CICP) Data

Aggregate Data as of May 1, 2022

The Countermeasures Injury Compensation Program (CICP) provides compensation for covered serious injuries or deaths that, based on compelling, reliable, valid, medical and scientific evidence, are found to be directly caused by the administration or use of a covered countermeasure or are determined to meet the requirements of a countermeasure injury table. Temporal association between administration or use of the covered countermeasure and onset of the injury (i.e., the injury occurs a certain time after the administration or use) is not sufficient, by itself, to prove that an injury is the direct result of a covered countermeasure.

It is important to note that the CICP data only captures the alleged countermeasure(s) and the alleged injuries that CICP requesters list on their Request for Benefits forms (RFB) or claim. The countermeasure or injury listed by the requester on the RFB may or may not be consistent with the requester’s medical documentation or the injury resulting in compensation. While requesters are required to identify the alleged countermeasure on their RFB form, they are not required to list the specific manufacturer or trade name on their RFB form.

Furthermore, while requesters must submit their RFB form within 1 year from the administration or use of the covered countermeasure, requesters are permitted to submit the necessary medical records and other documentation, such as a copy of a requester’s COVID-19 vaccination record, after the RFB is filed. For the majority of COVID-19 countermeasure claims, including COVID-19 vaccine claims, the CICP is still waiting for records and documentation to be submitted.

When was the first CICP claim filed?

The first CICP claim was filed in Fiscal Year (FY) 2010; there are no CICP claims to report on prior to FY 2010.

Is the CICP data available by specific manufacturer or trade name?

The CICP does not maintain its aggregated data concerning alleged countermeasures, including vaccines, by specific manufacturer.

How many claims has the CICP compensated?

The CICP is the payer of last resort and can only reimburse or pay for medical expenses or lost employment income that are not covered by other third-party payers. To date, the CICP has paid compensation for 29 CICP claims, totaling more than $6 million. An additional 10 CICP claims were eligible for compensation after a review of the required medical records and documentation; however, in these cases there were no eligible reported medical expenses or lost employment income for the CICP to compensate.

Has the CICP made any decisions regarding COVID-19 Claims?

As of May 1, 2022, the CICP has not compensated any COVID-19 countermeasures claims. Thirteen COVID-19 countermeasure claims have been denied compensation because the standard of proof for causation was not met and/or a covered injury was not sustained. One COVID-19 countermeasure claim, a COVID-19 vaccine claim due to an anaphylactic reaction, has been determined eligible for compensation and is pending a review of eligible expenses.

CICP Data for Fiscal Years 2010 – 2022 (As of May 1, 2022)

Total CICP Claims Filed: 8,506

• Claims Eligible for Medical Review: 8,411
  • Eligible for Compensation: 41
    • Compensated: 29
    • No Eligible Reported Expenses: 10
    • Pending: 2
  • Pending Review or In Review: 7,990
  • Denied: 380
    • Requested Medical Records not Submitted: 135
    • Standard of Proof Not Met and/or Covered Injury not Sustained: 245
• Claims Ineligible for Medical Review: 95
  • Missed Filing Deadline: 38
  • Not CICP Covered Product/Not Specified: 57

CICP claims data is provided below in categories pertaining to their status.

• Table 1. Claims filed alleging injuries and deaths from COVID-19 countermeasures
• Table 2. Non-COVID-19 countermeasure claims filed
• Table 3. Compensated claims
• Table 4. Eligible for compensation but no reported eligible expenses
• Table 5. Denied because required medical records were not submitted
• Table 6. Denied for failure to meet the standard of proof and/or sustain a covered injury
• Table 7. Ineligible for missing the filing deadline
• Table 8. Ineligible because product is not covered by CICP
• Table 9. Ineligible due to no allegation of administration or use of a covered countermeasure

Table 1. Alleged COVID-19 Countermeasure Claims Filed as of May 1, 2022

This table displays the alleged countermeasure and alleged injury/death for each COVID-19 countermeasure claim filed as of May 1, 2022. Of the 8,010 COVID-19 countermeasure claims, 5,033 allege injuries/deaths from COVID-19 vaccines and 2,997 allege injuries/deaths from other COVID-19 countermeasures.

The CICP does not maintain its aggregated data concerning alleged countermeasures, including vaccines, by specific manufacturer or trade name.